Carlsmed, Inc. Share-based Payment Arrangement, Expense
Carlsmed, Inc. (CARL) reported Share-based Payment Arrangement, Expense of $2.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-05
- Carlsmed, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $2.27M, a 780.23% increase year-over-year.
- Carlsmed, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $1.63M, a 830.86% increase year-over-year.
- Carlsmed, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $790.00K, a 690.00% increase year-over-year.
- Carlsmed, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $704.00K, a 966.67% increase year-over-year.
- Carlsmed, Inc. share-based payment arrangement, expense for fiscal 2025 was $1.93M, a 661.66% increase from fiscal 2024.
- Carlsmed, Inc. share-based payment arrangement, expense for fiscal 2024 was $253.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.27M 10-Q · filed 2026-08-05 | $3.90M 10-Q · filed 2026-08-05 | $4.69M derived: sum of 3 quarters · filed 2026-08-05 | $5.39M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.63M 10-Q · filed 2026-05-05 | $2.42M derived: sum of 2 quarters · filed 2026-05-05 | $3.12M derived: sum of 3 quarters · filed 2026-05-05 | $3.38M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $790.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.49M derived: sum of 2 quarters · filed 2026-02-25 | $1.75M derived: sum of 3 quarters · filed 2026-08-05 | $1.93M 10-K · filed 2026-02-25 |
| 2025-09-30 | $704.00K 10-Q · filed 2025-11-06 | $962.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.14M 10-Q · filed 2025-11-06 | $1.24M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $258.00K 10-Q · filed 2026-08-05 | $433.00K 10-Q · filed 2026-08-05 | $533.00K derived: sum of 3 quarters · filed 2026-08-05 | $599.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $175.00K 10-Q · filed 2026-05-05 | $275.00K derived: sum of 2 quarters · filed 2026-05-05 | $341.00K derived: sum of 3 quarters · filed 2026-05-05 | $393.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $166.00K derived: sum of 2 quarters · filed 2026-02-25 | $218.00K derived: sum of 3 quarters · filed 2026-02-25 | $253.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $66.00K 10-Q · filed 2025-11-06 | $118.00K derived: sum of 2 quarters · filed 2025-11-06 | $153.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $52.00K 10-Q · filed 2025-08-28 | $87.00K 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |